Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling.
Fibrosis can be an undesired consequence of activated cellular immune responses. The purpose of this work was to determine whether CD40 ligation and the pro-fibrotic cytokine IL-4 interact in regulating fibroblast proliferation and collagen production, and, if so, the mechanisms used. This study found that the combination of IL-4 and ligation of CD40 on the fibroblast cell surface had synergistic effects in stimulating fibroblast proliferation. In contrast, CD40 ligation negated the inhibitory effects of IFN-gamma on fibroblast proliferation. Western blotting analyses of fibroblast crude lysates revealed that a potential mechanism of the synergy between CD40 ligation and IL-4 was the phosphorylation of proteins at 130 kDa and, to a lesser degree, at 95, 85, and 75 kDa. Immunoprecipitation-Western blotting experiments showed that phosphorylation levels of IL-4Ralpha, Janus kinase 1, insulin receptor substrate 1, and insulin receptor substrate 2, factors with molecular mass close to the observed 130 kDa major phosphorylation band, increased in response to the combined CD40 ligation and IL-4 action. In contrast, there was no evidence that synergy was mediated by an increased expression of IL-4Ralpha chain, CD40, or the autocrine profibrotic cytokines IL-6 and TGF-beta. These findings suggest that CD40-CD40 ligand contacts between fibroblasts and cells secreting IL-4 may promote the profibrotic effects of IL-4 by affecting signal transduction and reducing the anti-fibrotic effects of IFN-gamma.
Atamas
Sergei P
SP
Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, MSTF 8-34, 10 South Pine Street, Baltimore, MD 21201, USA. satamas@umaryland.edu
Luzina
Irina G
IG
Dai
Heqiao
H
Wilt
Susan G
SG
White
Barbara
B
D019898:Autocrine Communication / Q000276:immunology; D023201:CD40 Ligand / Q000378:metabolism* / Q000502:physiology; D002455:Cell Division / Q000276:immunology; D002460:Cell Line; D016207:Cytokines / Q000096:biosynthesis; D004357:Drug Synergism; D005347:Fibroblasts / Q000166:cytology / Q000201:enzymology / Q000276:immunology* / Q000378:metabolism*; D006801:Humans; D015847:Interleukin-4 / Q000378:metabolism* / Q000502:physiology; D011505:Protein-Tyrosine Kinases / Q000502:physiology; D019948:Receptors, Interleukin-4 / Q000096:biosynthesis / Q000502:physiology*; D015398:Signal Transduction / Q000276:immunology*
D016207:Cytokines; D019948:Receptors, Interleukin-4; D023201:CD40 Ligand; D015847:Interleukin-4; D011505:Protein-Tyrosine Kinases